Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 Jun;48(6):447–454. doi: 10.1136/ard.48.6.447

Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively.

A J Swaak 1, J C Nossent 1, W Bronsveld 1, A Van Rooyen 1, E J Nieuwenhuys 1, L Theuns 1, R J Smeenk 1
PMCID: PMC1003786  PMID: 2742399

Abstract

This report presents an analysis of the cumulative survival in 110 well defined patients with systemic lupus erythematosus (SLE) who were followed up over a prolonged period of time. Special attention was paid to possible differences between patients who died and those who were still alive at the end of the study. Of the 110 patients with SLE, 96 (87%) were still alive after 10 years; the cumulative survival for men was 69% (11/16) and for women 90% (85/94). Patients who never developed a new exacerbation after the diagnosis for SLE had been established had a 10 year survival of 100%; for patients with one, two, or three exacerbations the 10 year survival was 91%, 69%, and 33% respectively. From these prospective studies it was found that the exacerbation frequency is most closely related to survival. Disease symptoms of renal involvement or neurological involvement, or both, present at the onset or at the moment the SLE diagnosis was established, were predominantly seen in patients who died during the follow up.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert D. A., Hadler N. M., Ropes M. W. Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus? Arthritis Rheum. 1979 Sep;22(9):945–953. doi: 10.1002/art.1780220901. [DOI] [PubMed] [Google Scholar]
  2. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  3. DUBOIS E. L. The effect of the L. E. cell test on the clinical picture of systemic lupus erythematosus. Ann Intern Med. 1953 Jun;38(6):1265–1294. doi: 10.7326/0003-4819-38-6-1265. [DOI] [PubMed] [Google Scholar]
  4. Estes D., Christian C. L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 Mar;50(2):85–95. doi: 10.1097/00005792-197103000-00001. [DOI] [PubMed] [Google Scholar]
  5. Feinglass E. J., Arnett F. C., Dorsch C. A., Zizic T. M., Stevens M. B. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976 Jul;55(4):323–339. doi: 10.1097/00005792-197607000-00004. [DOI] [PubMed] [Google Scholar]
  6. Fessel W. J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974 Dec;134(6):1027–1035. [PubMed] [Google Scholar]
  7. Ginzler E. M., Diamond H. S., Weiner M., Schlesinger M., Fries J. F., Wasner C., Medsger T. A., Jr, Ziegler G., Klippel J. H., Hadler N. M. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982 Jun;25(6):601–611. doi: 10.1002/art.1780250601. [DOI] [PubMed] [Google Scholar]
  8. Grigor R., Edmonds J., Lewkonia R., Bresnihan B., Hughes G. R. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis. 1978 Apr;37(2):121–128. doi: 10.1136/ard.37.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hashimoto H., Tsuda H., Hirano T., Takasaki Y., Matsumoto T., Hirose S. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol. 1987 Jun;14(3):497–501. [PubMed] [Google Scholar]
  10. KELLUM R. E., HASERICK J. R. SYSTEMIC LUPUS ERYTHEMATOSUS. A STATISTICAL EVALUATION OF MORTALITY BASED ON A CONSECUTIVE SERIES OF 299 PATIENTS. Arch Intern Med. 1964 Feb;113:200–207. doi: 10.1001/archinte.1964.00280080036008. [DOI] [PubMed] [Google Scholar]
  11. Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., Ogryzlo M. A. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 Jan;46(181):1–32. [PubMed] [Google Scholar]
  12. Lightfoot R. W., Jr, Hughes G. R. Significance of persisting serologic abnormalities in SLE. Arthritis Rheum. 1976 Sep-Oct;19(5):837–843. doi: 10.1002/art.1780190501. [DOI] [PubMed] [Google Scholar]
  13. McCOMBS R. P., PATTERSON J. F. Factors influencing the course and prognosis of systemic lupus erythematosus. N Engl J Med. 1959 Jun 11;260(24):1195–1204. doi: 10.1056/NEJM195906112602401. [DOI] [PubMed] [Google Scholar]
  14. ROPES M. W. OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS. Medicine (Baltimore) 1964 May;43:387–391. doi: 10.1097/00005792-196405000-00016. [DOI] [PubMed] [Google Scholar]
  15. Rubin L. A., Urowitz M. B., Gladman D. D. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med. 1985 Apr;55(216):87–98. [PubMed] [Google Scholar]
  16. Swaak A. J., Groenwold J., Aarden L. A., Feltkamp T. E. Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis. 1981 Feb;40(1):45–49. doi: 10.1136/ard.40.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Swaak A. J., Groenwold J., Aarden L. A., Statius van Eps L. W., Feltkamp E. W. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis. 1982 Aug;41(4):388–395. doi: 10.1136/ard.41.4.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Swaak A. J., Groenwold J., Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis. 1986 May;45(5):359–366. doi: 10.1136/ard.45.5.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Swaak A. J., van Rooyen A., Vogelaar C., Pillay M., Hack E. Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course. Rheumatol Int. 1986;6(5):221–226. doi: 10.1007/BF00541371. [DOI] [PubMed] [Google Scholar]
  20. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  21. Urman J. D., Rothfield N. F. Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA. 1977 Nov 21;238(21):2272–2276. [PubMed] [Google Scholar]
  22. Urowitz M. B., Bookman A. A., Koehler B. E., Gordon D. A., Smythe H. A., Ogryzlo M. A. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976 Feb;60(2):221–225. doi: 10.1016/0002-9343(76)90431-9. [DOI] [PubMed] [Google Scholar]
  23. Wallace D. J., Podell T., Weiner J., Klinenberg J. R., Forouzesh S., Dubois E. L. Systemic lupus erythematosus--survival patterns. Experience with 609 patients. JAMA. 1981 Mar 6;245(9):934–938. doi: 10.1001/jama.245.9.934. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES